Fingerprint
Dive into the research topics of 'Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial
Shaakir Hasan, Stanislav Lazarev, Madhur Garg, Rachel Gozland, John Chang, William Hartsell, Jonathan Chen, Henry Tsai, Carlos Vargas, Charles B. Simone, Daniel Gorovets
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations